Abstract
Mari De La Rosa Takashima, Brett Paul Dyer, Amanda Judith Ullman, Robert S. Ware
Abstract
Authors
Institutions
Provenance
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review
10.1186/s12874-021-01440-5 · 2021
Combined endpoints: can we use them?
10.1002/sim.1300 · 2002
Composite outcome measures in high‐impact critical care randomised controlled trials: a systematic review
10.1186/s13054-024-04967-3 · 2024
Unresolved referenced work
2015
Making sense of composite endpoints in clinical research
10.3390/jcm12134371 · 2023
Integrated versus nonintegrated peripheral intravenous catheter in hospitalized adults (OPTIMUM): a randomized controlled trial
10.1002/jhm.12995 · 2023
Impact of pharmacist involvement in the transitional care of high‐risk patients through medication reconciliation, medication education, and postdischarge call‐backs (IPITCH Study)
10.1002/jhm.2493 · 2016
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
10.1038/s41591-021-01659-1 · 2022
Guidelines for reporting outcomes in trial reports: the CONSORT‐outcomes 2022 extension
10.1001/jama.2022.21022 · 2022
crossref
Confidence 100%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
The problem with composite end points in cardiovascular studies
10.1016/j.jacc.2007.10.034 · 2008
Clinical and safety impact of an inpatient pharmacist‐directed anticoagulation service
10.1002/jhm.910 · 2011
Beyond bloodstream infection: the potential for hierarchical composite endpoints in vascular access research
10.1093/cid/ciag276 · 2026
Effects of extended‐release metoprolol succinate in patients undergoing non‐cardiac surgery (POISE trial): a randomised controlled trial
10.1016/s0140-6736(08)60601-7 · 2008
Composite outcomes in randomized trials: greater precision but with greater uncertainty?
10.1001/jama.289.19.2554 · 2003
The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
10.1093/eurheartj/ehr352 · 2012
Angiotensin‐neprilysin inhibition in heart failure with preserved ejection fraction
10.1056/nejmoa1908655 · 2019
Weighted reverse counting process (WRCP): a novel approach to quantify the overall treatment effect with multiple time‐to‐event outcomes by adaptive weighting
2024
Joint modeling of endpoints can be used to answer various research questions in randomized clinical trials
10.1016/j.jclinepi.2022.03.009 · 2022
Joint modeling of endpoints can be used to answer various research questions in randomized clinical trials
10.1016/j.jclinepi.2022.03.009 · doi-reference
Angiotensin‐neprilysin inhibition in heart failure with preserved ejection fraction
10.1056/nejmoa1908655 · doi-reference
The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
10.1093/eurheartj/ehr352 · doi-reference
Composite outcomes in randomized trials: greater precision but with greater uncertainty?
10.1001/jama.289.19.2554 · doi-reference
Effects of extended‐release metoprolol succinate in patients undergoing non‐cardiac surgery (POISE trial): a randomised controlled trial
10.1016/s0140-6736(08)60601-7 · doi-reference
Beyond bloodstream infection: the potential for hierarchical composite endpoints in vascular access research
10.1093/cid/ciag276 · doi-reference
Clinical and safety impact of an inpatient pharmacist‐directed anticoagulation service
10.1002/jhm.910 · doi-reference
The problem with composite end points in cardiovascular studies
10.1016/j.jacc.2007.10.034 · doi-reference
Guidelines for reporting outcomes in trial reports: the CONSORT‐outcomes 2022 extension
10.1001/jama.2022.21022 · doi-reference
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
10.1038/s41591-021-01659-1 · doi-reference
Impact of pharmacist involvement in the transitional care of high‐risk patients through medication reconciliation, medication education, and postdischarge call‐backs (IPITCH Study)
10.1002/jhm.2493 · doi-reference
Integrated versus nonintegrated peripheral intravenous catheter in hospitalized adults (OPTIMUM): a randomized controlled trial
10.1002/jhm.12995 · doi-reference
Making sense of composite endpoints in clinical research
10.3390/jcm12134371 · doi-reference
Composite outcome measures in high‐impact critical care randomised controlled trials: a systematic review
10.1186/s13054-024-04967-3 · doi-reference
Combined endpoints: can we use them?
10.1002/sim.1300 · doi-reference
Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review
10.1186/s12874-021-01440-5 · doi-reference